Equine trait mapping by Andersson, Lisa S.
Equine Trait Mapping 
From Disease Loci to the Discovery of a Major Gene 
Controlling Vertebrate Locomotion 
Lisa S Andersson 
Faculty of Veterinary Medicine and Animal Science 
Department of Animal Breeding and Genetics 
Uppsala 
Doctoral Thesis 
Swedish University of Agricultural Sciences 
Uppsala 2012  
Acta Universitatis agriculturae Sueciae 
2012:65 
ISSN 1652-6880 
ISBN 978-91-576-7712-9 
© 2012 Lisa S Andersson, Uppsala 
Print: SLU Service/Repro, Uppsala 2012  
 
Equine Trait Mapping. From Disease Loci to the Discovery of a 
Major Gene Controlling Vertebrate Locomotion. 
Abstract 
Assigning  function  to  genes  is  essential  for  a  better  understanding  of  biological 
systems. To date, approximately half of the genes in the vertebrate genome have known 
function. Domestic animals are a rich source for trait mapping and in this thesis we 
have  mapped  three  distinct  equine  phenotypes.  The  result  provides  increased 
knowledge regarding gene function and importantly, practical implications for horse 
welfare.  In  paper  I  and  IV,  we  confirm  that  Equine  Multiple  Congenital  Ocular 
Anomalies  (MCOA)  syndrome  is  inherited  as  an  incompletely  dominant  trait  (p= 
2.2x10
-16).  By  first  identifying  a  208  kb  identity-by  decent  (IBD)  region  and 
subsequently excluding polymorphic sites identified through Illumina sequencing, we 
conclude that the gene PMEL causes these defects in horse. Our findings, together with 
functional analyses recently published, support that the cause of MCOA syndrome is a 
missense mutation (Arg625Cys) near the transmembrane region of PMEL that results 
in altered biochemical properties. In paper II we show that variants in the MHC-II 
region influence the susceptibility to equine Insect Bite Hypersensitivity with the same 
marker risk allele identified in two distinct populations, OR 4.19 (p= 2.3x10
-5) and 1.48 
(p=  0.04)  for  Icelandic  horses  and  Exmoor  ponies  respectively.  In  addition, 
homozygosity across the MHC-II region confers a higher risk of developing disease, 
OR= 2.67 (p= 1.3x10
-3). Finally, in paper III we utilize the EquineSNP50 BeadChip to 
identify the first Gait locus in horse. A highly significant SNP (EMP2= 2.0x10
-4) was 
identified to be consistent with a recessive mode of inheritance for the lateral gait pace 
in  Icelandic  horses,  and  confirmed  in  an  independent  sample  set  (p=  2.4x10
-14). 
Illumina sequencing of an established IBD region identified a nonsense mutation in the 
gene DMRT3. A clearly dichotomous distribution in a panel of gaited and non-gaited 
breeds revealed that the DMRT3 mutation is permissive for a variety of alternate gaits. 
The  mutation  also  has  a  favorable  effect  in  harness  racing  horses.  Functional 
characterization of the truncated protein demonstrated correct localization and an intact 
DNA binding profile. mRNA expression in a small population of commissural neurons 
from the spinal cord was confirmed in mutant and wild type horses. Further, a DMRT3 
null mouse displayed a change in spinal cord circuit signaling and locomotion. These 
findings reveal a new molecule involved in the regulation of limb movement. 
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Introduction 
Genomic studies in horses have, in many regards, been facilitated by similar 
studies in other species such as in human and mouse. The genome projects of 
these species, and later that of the horse, were initiated with the construction of 
whole genome linkage maps, mainly consisting of microsatellite marker data. 
Following the development of Sanger sequencing technology, a draft version 
of the human genome was available in 2000 (Lander et al., 2001; Venter et al., 
2001). The horse was actually one of the first placental animals with a fully 
sequenced genome and a draft version was completed by 2007 (Wade et al., 
2009). As part of these sequencing efforts, a large number of single nucleotide 
polymorphisms (SNPs) were identified and commercial SNP chips developed. 
These technologies revolutionized genetic trait mapping, in part by speeding up 
the  previously  very  time  consuming  and  labor  intense  genotyping  process. 
Today, extremely high throughput sequencing, which produce an increasing 
amount  of  data  at  a  rapidly  declining  cost,  have  become  an  attractive 
alternative to SNP chips. For instance, the human genome sequencing funded 
by  Celera  Genomics  took  three  years  to  complete  and  had  a  budget  of 
approximately US$300,000,000. In 2011, we sequenced the whole genome of 
two horses in just a few days and at a cost of approximately $18,000. The past 
20 years has truly been a golden age for molecular genetics. The remarkable 
developments in technology have been followed by a burst in the number of 
genes  identified  to  be  associated  with  phenotypic  traits  and  improved  our 
understanding of the genome in terms of regulation, recombination, mutation, 
transposable elements and evolution. 
 
However, further research is required before we fully understand the human 
genome. To date, we only have functional information, vague for some, on 
approximately half of the ~21,000 genes in the mammalian genome (Alberts, 
2011). There is an interesting two-way relationship joining the research of the   12 
human genome and that of domestic animals such as the horse. The human 
genome was instrumental in the annotation of genes within the horse genome; 
over 16,000 are orthologous (Wade et al., 2009). However, genetic research in 
domestic  animals  and  in  other  model  organisms  can  be  integral  to  the 
functional annotation of the human genome i.e. what is the purpose of each 
gene product. Functional annotation is vital in order to increase our knowledge 
about  the  human  body  and  assist  in  disease  prevention,  diagnostics  and 
treatment.  Forward  genetics,  such  as  knocking  out  genes  in  mouse  and 
zebrafish, is one way of characterizing gene functions. An alternative approach 
is reverse genetics, starting with the recognition of an interesting heritable trait 
followed  by  the  identification  of  the  causative  gene  and  mutation.  The 
identification  of  causal  variants  sometimes  takes  advantage  of  comparative 
information from similar disorders or traits in other species. All mapped traits 
will add to this knowledge bank and will help scientists working with different 
species worldwide. 
 
Molecular  genetic  research  in  domestic  animals  is  also  important  from  an 
animal welfare and/ or breeding scheme perspective. Once genomic mutations 
or even genomic regions harboring quantitative trait loci (QTLs) have been 
identified, marker assist selection can be utilized to select for desirable traits 
and against disease. This is also important from an ethical perspective, since it 
is our responsibility to breed healthy animals suited to their purpose. The aim 
of the studies included in this thesis was thus two-fold. First, to use the power 
of  domestic  animal  genetics  to  assign  function  to  mammalian  genes  and 
secondly, to use the results to address equine breeding schemes and animal 
welfare concerns. 
 
The use of domestic animals for assigning function to genes 
Selection has caused an accumulation of mutations 
Domestic animals are a fantastic resource for gene mapping. For thousands of 
years,  since  the  dawn  of  domestication,  humans  have  selected  spontaneous 
mutations in farm and companion animals. These mutations include those with 
an obvious phenotypic effect, such as coat color, but also those with a more 
subtle  effect  on  traits  such  as  behavior,  disease  resistance  and  production. 
Horses have similarly been selected for athletic performance traits. As a result, 
domesticated animals are much more phenotypically diverse than their wild 
ancestors. Artificial selection has caused an accumulation of both positive and 
negative mutations and has thus created a pool that can be exploited in gene   13 
mapping studies. The results from such experiments may serve to elucidate the 
function  of  different  genes  in  the  mammalian  genome,  including  humans 
(Andersson & Georges, 2004; Andersson, 2001). Bottlenecks, genetic drift and 
natural adaptations further add to the phenotypic diversity seen in domestic 
animals. 
 
A fundamental reason for using domestic animals in disease trait mapping lies 
in the fact that loci with large effects are more easily mapped than loci with 
small effects. Because of small population sizes and strong human artificial 
selection,  numerous  highly  penetrant  mutations  (causing  different  traits  and 
diseases)  are  present  in  relatively  high  frequency  in  domestic  animals 
compared to the human race. Genetic hitchhiking or the extensive spread of 
recessive alleles through the use of popular sires, will also affect a population’s 
gene frequency. A recessive mutation has to reach a sufficiently high allele 
frequency before breeders become aware of the phenotypic problem, however 
once such disease is identified, it can now be quite straightforward to map the 
causative loci using only a few diseased and healthy animals (Charlier et al., 
2008). In yet other cases, highly penetrant, deleterious mutations can actually 
be selected for unintentionally. This occurs when a mutation that confers a 
valuable trait also has negative pleiotropic effects. Genetically this can be seen 
as heterozygous individuals displaying the valuable trait whilst homozygous 
individuals display an additional disease phenotype. The Rhodesian ridgeback 
dog breed provides one such example. The desired dorsal hair ridge is caused 
by  a  dominant  133  kilo  base  (kb)  duplication,  however  dogs  that  are 
homozygous for the duplication have a much higher risk of developing the 
neural-tube  defect,  dermoid  sinus  (Salmon  Hillbertz  et  al.,  2007).  Multiple 
Congenital Ocular Anomalies (MCOA) syndrome characterized in paper I is 
another example. It has a high frequency in several horse breeds as the same 
mutation also causes the valued Silver coat color. 
 
Why are domestic animals a good model? 
There are several reasons why domestic animals are of significant value for 
trait  mapping  compared  to  humans  (Andersson,  2009;  Goddard  &  Hayes, 
2009; Georges, 2007): 
 
I  Easy  access  to  large  pedigrees,  either  through  the  creation  of  an 
experimental cross or by taking advantage  of existing  farm animals  and 
their corresponding pedigree records. Pedigrees are particularly valuable for 
linkage mapping, but they also facilitate the phasing of alleles.   14 
 
II  Easier  to  collect  tissues  samples  compared  to  in  humans.  However,  for 
companion animals such as dogs and horses, some tissues are obviously 
problematic to collect. 
 
III  Higher  linkage  disequilibrium  (LD),  especially  within  breeds.  Between 
breeds the LD is lower. This makes mapping in domestic animals favorable 
since one can take advantage of the high LD within breeds for genome 
scans and the low LD between breeds for fine mapping, a so called two-
stage approach (Lindblad-Toh et al., 2005). 
 
IV  Often reduced environmental noise because of comparable housing across 
the whole population. 
 
V  An enrichment of mutations with large effects. 
 
VI  The  same  trait  is  often  present  in  several  breeds,  which  facilitates  both 
mapping and the confirmation of genetic results. This phenomena can be 
due to gene flow or because breeds share a common ancestor that carried 
the  trait-causing  mutation.  In  horses,  one  or  a  few  individuals  (usually 
stallions), with a particular desired trait are commonly intercrossed between 
breeds to improve it. In fact, there is not a single known coat color unique 
to any one breed (Bowling & Ruvinsky, 2000). 
 
VII Less genetic heterogeneity including (i) locus heterogeneity, which is the 
case when different genes are responsible for similar phenotypes and (ii) 
allelic  heterogeneity,  which  is  the  presence  of  different  alleles  within  a 
single gene causing similar phenotypes. In humans genetic heterogeneity is 
common. For example, over 1,000 different mutations in the gene cystic 
fibrosis transmembrane conductance regulator (CFTR) are associated with 
cystic  fibrosis  (Andersson,  2009).  In  contrast,  many  breeds  of  domestic 
animals have small effective population sizes and thus a high degree of 
homogeneity. 
 
Most of the facts presented above have been taken advantage of in order to 
complete  either  the  research  presented  in  this  thesis,  or  the  preliminary 
experiments upon which this thesis work is based. For example, pedigrees were 
used in the linkage analysis of MCOA syndrome (not included here) and in the 
phasing of major histocompatibility complex (MHC) class II haplotypes (paper 
II),  tissues  from  both  live  and  slaughtered  animals  were  collected  for  all   15 
projects and the relatively high LD in horse was explored in the pace genome-
wide association study (GWAS) (paper III). In addition, in the study of MCOA 
syndrome (paper I) we used haplotype analysis across four different breeds to 
narrow the genetic interval and in the pace study (paper IV) we genotyped 
additional horse breeds and found the same causative mutation in a large subset 
of these. 
 
The clear benefits of domestic animals compared to human populations for trait 
mapping have been highlighted, however, when performing this task in any 
species  there are several aspects  that  must  be  taken into consideration.  For 
instance,  when setting  up  the  experimental  design  the  predicted  inheritance 
pattern, genome structure of the particular animals and resources at hand must 
all be weighed. 
 
Mapping traits genes 
Complex versus monogenic traits 
A complex trait, also called a multifactorial or quantitative trait, depends on the 
cumulative action of many genes as well as environmental factors. In contrast, 
a  monogenic  trait,  also  called  a  Mendelian  trait,  is  not  influenced  by  the 
environment and is affected by only one gene. The study of monogenic traits 
began with the Austrian scientist Gregor Mendel and his research on peas and 
flowers  at  the  beginning  of  the  19th  century.  Monogenic  traits  have  been 
essential in revealing the mechanisms of heredity and represent the majority of 
mapped mutations. Thousands of QTL have also been mapped (Andersson, 
2009)  but in only a small fraction of these  has the  causative mutation, the 
quantitative  trait  nucleotide  (QTN),  been  identified.  Three  commonly  cited 
studies where the QTN has been determined are the muscle growth influencing 
insulin-like growth factor 2 (IGF2) loci in pigs and the myostatin (MSTN) gene 
in sheep (Clop et al., 2006; Van Laere et al., 2003) and the milk fat content 
effecting  acyl-coenzyme  A:diacylglycerol  Acyltransferase  (DGAT1)  gene  in 
cattle (Grisart et al., 2002). 
 
Additional  QTNs  have  been  identified  through  their  effect  on  monogenic 
disorders.  An  example  of  such  is  the  missense  mutation  in  the  ryanodine 
receptor  1  (RYR1)  gene  causing  a  monogenic  disorder  called  malignant 
hyperthermia; later proved to influence lean muscle mass in pigs (Fujii et al., 
1991).  Another  example  is  illustrated  by  the  mutations  in  the  gene  serine 
peptidase  inhibitor,  kazal  type  5  (SPINK5).  They  cause  a  rare  recessive   16 
disorder called Netherton syndrome (Chavanas et al., 2000), and were later 
also associated with atopic dermatitis (Walley et al., 2001). We investigated if 
polymorphisms  in  this  gene  were  associated  with  equine  Insect  Bite 
Hypersensitivity  (IBH),  but  no  such  correlation  could  be  established 
(Andersson et al., 2009). The doublesex and mab-3 related transcription factor 
3 (DMRT3) nonsense mutation described in paper III of this thesis, is another 
example that can be added to the list of known QTNs. It was first identified 
when we studied the recessive trait “pace” in Icelandic horses. We have now 
shown  that  the  DMRT3  QTN  has  a  large  effect  on athletic  performance  in 
harness  racing  horses.  Similarly,  the  myostatin  gene  has  been  shown  to  be 
involved  in  athletic  performance  traits  in  horse  with  different  genotypes 
correlating with optimum race distance in Thoroughbreds (Binns et al., 2010; 
Hill et al., 2010). 
 
The  lack  of  significant  association  in  many  GWAS  of  complex  traits  may 
support Fisher’s traditional infinitesimal model which assumes a very large 
(infinite) number of loci each have extremely small effects. However, the fact 
that QTNs with a measurable effect on quantitative traits have been identified 
supports the alternate so-called quasi- infinitesimal model i.e. the segregation 
of genes with large effects for complex traits. The relative weight between 
these  two  theories  has  long  been  debated.  Our  finding,  that  the  DMRT3 
nonsense  mutation  has  a  large  effect  on  racing  performance,  supports  the 
quasi- infinitesimal model and may give assurance that there are still genes 
with large effect on complex traits left to be identified. 
 
Unfortunately,  it  is  hard  to  know  beforehand  if  there  is  a  major  locus 
segregating for any given trait. The heritability of a trait is a poor predictor of 
effect sizes. One example is height in humans. Even though it has a heritability 
estimate  of  ~80%,  the  hundreds  of  genetic  variants  identified  to  date  only 
explain  ~10%  of  the  phenotypic  variation  (Lango  Allen  et  al.,  2010).  In 
contrast,  the  results  from  our  study  of  pace  (paper  III)  provides  a  very 
interesting  example  of  a  phenotype  that  was  long  considered  to  be  a 
quantitative trait with a heritability estimate of 60% (Albertsdottir et al., 2011), 
but  by  changing  the  phenotypic  classifications  we  were  able  to  identify  a 
monogenic component. The quality of the pace is still a quantitative character, 
but the DMRT3 nonsense mutation is permissive for ability to pace and has a 
simple recessive mode of inheritance in Icelandic horses. 
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Mapping strategies 
There are two different major strategies most commonly adopted to map trait 
genes; (i) the candidate gene approach and (ii) an unprejudiced approach where 
one searches the entire genome in order to find a chromosomal region, and 
ultimately  the  gene,  causing  the  phenotype  of  interest.  The  later  can  be 
performed  either  by  genotyping  evenly  distributed  markers  or  by  whole 
genome sequencing. In the candidate gene approach, a gene is selected based 
on knowledge about gene function. If one manages to predict the correct gene, 
this approach can be extremely fast and cheap. However, it often fails due to 
our  limited  knowledge  about  the  function  of  many  genes.  In  the  studies 
presented  here,  we  have  utilized  both  strategies.  In  paper  I,  we  used  the 
candidate  gene  approach  and  genotyped  markers  in  the  vicinity  of  the 
premelanosome protein (PMEL) gene in order to find the mutation causing 
MCOA  syndrome.  The  PMEL  gene  had  previously  been  selected  as  a 
candidate  gene  for  Silver  coat  color  because  of  its  known  association  to 
hypopigmented  phenotypes  in  other  species.  Likewise,  the  MHC-II  region 
investigated in paper II, had been linked to various allergic phenotypes in other 
species, making it a obvious candidate region for equine IBH. In contrast, there 
weren’t any convincing candidate genes for the ability to pace and we therefore 
performed a genome-wide scan using the Illumina equine50kSNP chip. 
 
Two common methodologies for establishing connections between phenotype 
and genotype are linkage mapping and association mapping. Historically, when 
genotyping  was  a  very  laborious  and  time-consuming  process,  linkage 
mapping was readily used because this approach requires fewer markers. In 
linkage mapping one quantifies the co-segregation of marker alleles and a trait 
within a pedigree. When DNA is replicated and inherited from parent to child 
it is passed on in large chromosome blocks. This is caused by the fact that the 
number of recombinations in a single meiosis is relatively low. Each marker 
can therefore tag a large region and so fewer markers are necessary to cover 
the entire genome. As a consequence, the identified chromosomal region(s) are 
usually very large, which is a drawback in most linkage studies. In contrast, 
association analysis investigates subjects from a whole population and so takes 
advantage of historical recombination. This generally results in much shorter 
chromosomal regions, but requires more markers. With today’s technological 
advances,  such  as  SNP  chips  and  whole  genome  re-sequencing,  this  is  no 
longer  a  major  problem.  All  studies  presented  in  this  thesis  are  based  on 
association mapping. 
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Yet  another  mapping  strategy  is  Fst-  and  selective  sweep  scans.  These  are 
particularly  useful  for  finding  regions  with  large  differences  in  allele 
frequencies  between  populations  or  when  one  expects  that  there  has  been 
strong  selection  for  a  particular  trait,  in  turn  leading  to  long  homozygous 
stretches. These methodologies can be utilized when a breed is thought to be 
fixed  for  a  mutation;  an  instance  where  neither  linkage  nor  association 
mapping can be applied because of their dependence of segregation. Sweep or 
Fst scans can be performed on both whole genome sequencing data (Rubin et 
al., 2010) or SNP chip data (Vaysse et al., 2011). One major drawback with 
these  scans  however,  is  that  it  may  be  difficult  to  establish  the  actual 
phenotypic characteristics causing significant signals. 
 
Factors that influence GWAS 
Many issues such as mutation effect size, density of informative markers, the 
degree of LD and the number of genotyped subjects, influence the success of 
GWAS. Several of these entities can, to some extent, be compensated for by 
each other e.g., one needs to increase the number of subjects if the mutation 
effect size is small or if the LD between marker and mutation is low. A major 
advantage of using domestic animals over humans is in fact the higher within 
breed  LD  that  directly  affects  the  number  of  markers  needed  for  a  whole 
genome scan. For example, the newest dog SNP chip contains 170,000 markers 
and the horse chip 74,000. In contrast, significant LD in human usually only 
extends for tens of kb (Gabriel et al., 2002) and the newest human SNP chip 
therefore contains over one million markers. However, LD varies significantly 
between different populations even within species. 
 
A very important aspect to keep in mind when performing GWAS is the risk of 
false positives due to population stratification. This phenomenon occurs when 
a population is divided into sub-groups displaying both different marker allele 
and  disease  frequency.  This  is  common  in  domestic  animals  and  is  often 
caused by the use of popular sires. Population stratification can be detected by 
comparing the observed with the expected distribution of p-values. Obviously, 
false positives can also be caused when an inappropriate method is used to 
correct  for  multiple  testing.  This  is  a  central  aspect  of  GWAS  when 
considering that many thousands of statistical tests are executed. Bonferroni 
correction assumes independency between tests. This is usually not the case for 
GWAS because of LD between adjacent markers and this correction is thus 
usually considered to be too stringent. In the GWAS presented in this thesis we 
have used permutations to correct for multiple testing.   19 
 
A  downside  to  association  studies  lies  in  the  fact  that  it  is  impossible  to 
establish association if the haplotype on which the mutation first arose, the 
ancestral haplotype, is common within the population. We have performed two 
separate GWAS for monogenic traits in horse (data not shown) and one reason 
for the lack of significant results may be that the disease mutation is not tagged 
by  any  unique  SNP.  Another  problematic  scenario  is  if  there  are  multiple 
causative alleles at a single locus. If these are tagged by opposite marker alleles 
the association signals might cancel each other out. 
 
Fine mapping and the identification of causal variants 
The  size  of  the  trait  identity-by-decent  (IBD)  region  depends  both  on  the 
number  of  recombination  events  that  have  occurred  since  the  mutation 
appeared and on the selective pressure attached to it. If the mutation is recent, 
there will be a large IBD region common to all cases. This may facilitate the 
identification of the region but makes identification of causal variants much 
more difficult. Today, a helpful strategy is to sequence the whole region using 
next generation technology, which identifies all polymorphic sites where cases 
and  controls  differ.  In  paper  IV  we  performed  long  range  PCRs  prior  to 
sequencing,  but  other  methodologies  such  as  sequence  capture  can  also  be 
applied. With the continuing drop in sequencing cost, we decided to sequence 
the entire genome of two horses in paper III. Reads aligning to the established 
IBD region were subsequently extracted and analyzed. When sequencing large 
regions, one usually ends up with a very large number of potential causative 
mutations. A way to overcome this, especially useful for monogenic traits, is to 
choose controls with an ancestral haplotype or haplotypes very similar to the 
disease haplotype. We utilized this approach in paper IV, and the result was 
just two candidate mutations. In fact, unless the mutation happened on a very 
uncommon haplotype chances are quite high that the ancestral haplotype still 
resides in the current population of domestic animals (Andersson, 2009). 
 
If the ancestral haplotype could not be identified, and/or if the trait is complex 
and  thus  without  a  dichotomous  phenotypic  classification,  numerous 
polymorphic sites are usually identified as potentially causative. In these cases, 
one can first focus on the sites that are either in coding regions or in conserved 
elements such as those identified through the 29 mammals project (Lindblad-
Toh et al., 2011). In the pace project presented in paper III we identified 65 
polymorphic sites within the sequenced 438 kb IBD region. One of these was a 
very good candidate for functional validation since it introduced a stop codon   20 
into a transcription factor. There is an obvious pitfall to this methodology, it 
will not detect a gain of function mutation generated within an “unconstrained” 
region, for instance the generation of a transcription factor binding site. Many 
times no obvious candidate mutation can be identified. The usual methodology 
is then to genotype all the polymorphic sites in a large number of subjects, here 
even individuals that do not carry the trait are of value since they can be used 
to exclude causality. Further, quantitative PCR (qPCR) can be used to test for 
differential gene expression within the associated region, which could aid in 
the identification of the most likely candidate. 
 
Obviously  fine  mapping  monogenic  traits,  which  have  a  simple  one-to-one 
relationship  between  genotype  and  phenotype,  is  much  easier  than  fine 
mapping QTLs. Identification of the actual QTNs is hampered by the difficulty 
in assigning an exact phenotypic class to each sample. Here, domestic animals 
potentially have a very convenient advantage over human studies. Although the 
quantitative trait is a metric value, for each locus individuals can be defined 
categorically (except for multi-allelic mutations such as multiple duplications). 
Sometimes the genotype of an individual at any given QTL can be determined 
by the phenotypic distribution of the trait among their progeny, at least if the 
effect size is high (Van Laere et al., 2003). 
 
Functional validation 
Depending  on  the  nature  of  the  causative  mutation,  different  functional 
validation  strategies  can  be  adopted.  For  example,  if  the  mutation  is  in  a 
predicted  promoter  or  enhancer  element,  the  amount  of  mRNA  in  mutant 
versus wild type (wt) subjects can be measured using qPCR. Mutations in the 
3’ and 5’ end of genes can also influence mRNA stability. Stop mutations 
commonly  subject  the  mRNA  to  nonsense-mediated  decay.  If  the  mutation 
alters amino acid sequence, one can test if the protein retains its biochemical 
properties through enzymatic assays, signaling assays, or investigate its ability 
to form correct structures etc. The binding properties of mutated transcription 
factors can be analyzed with electrophoretic mobility shift assay (EMSA) and 
their  capacity  to  regulate  expression  with  luciferase  assays.  Mutations  that 
cause changes in the signal peptide sequence are a special case, as these can 
direct the protein to the wrong locality. This error may be elucidated by green 
fluoresces  protein  (GFP)  tagging.  A  fantastic  resource  for  the  functional 
validation  of  mutations  is  to  either  disrupt  the  gene  in  mouse,  a  so-called 
knockout mouse, or to induce the exact same mutation, a knock-in mouse. This   21 
section by no means covers all functional validations that can be performed, 
but gives a short outline of some the most commonly used methods. 
 
The horse 
History of the horse 
The  horse  (Equus  caballus)  belongs  to  the  order  Perissodactyla  (odd-toed 
hoofed mammals). There are three existing families in this order: the Equidae 
(horses,  asses  and  zebras),  the  Rhinocerotidae  (rhinos)  and  the  Tapiridae 
(tapirs). The horse was domesticated on the Eurasian steppe 5,000-6,000 years 
ago  (Ludwig  et  al.,  2009).  They  do  not  seem  to  have  undergone  a  tight 
domestication  bottleneck,  rather  both  genetic  and  archaeological  evidence 
suggests  multiple  domestication  events  (Cieslak  et  al.,  2010;  Jansen  et  al., 
2002; Vila et al., 2001) and the high diversity seen in maternal linages suggests 
continued gene flow between domestic and wild stock (Lippold et al., 2011b). 
In contrast, sequence analysis of the Y-chromosome suggests a limited number 
of  patrilines  (Lippold  et  al.,  2011a),  indicating  a  strong  sex  bias  in  the 
domestication process. Horses throughout history have played an important roll 
in human civilization through transportation, use in agriculture, service in war, 
food production and as sport- and companion animals. Horses have primarily 
been  bred  for  performance  and  health  and  the  major  selective  focus  is  on 
athletic traits i.e. mutations that influence riding or driving. This is probably 
the main reason why horses are not as morphologically diverse, or extreme, as 
many dog breeds. Still, there has been some selection for fancy phenotypes 
such  as  coat  color  and  miniature  stature.  There  are  approximately  500 
recognized  horse  breeds  and  the  worldwide  population  is  greater  than  58 
million  (FAOSTAT  2007).  There  is  much  long-range  haplotype  sharing 
between breeds, at least in comparison to dogs, suggesting a close interbreed 
relationship  and  gene  flow  between  many  horse  populations  (Wade  et  al., 
2009). 
 
Historic background to the field of horse genetics 
The  horse  has  32  pairs  of  chromosomes  (2n=  64)  including  the  sex 
chromosomes as revealed in 1959 (Rothfels et al., 1959). Investigations into 
the  mode  of  inheritance  for  coat  colors  marked  the  start  of  horse  genetic 
research in the beginning of the 20
th century (Hurst, 1906). The first markers to 
be  used  with  the  aim  of  constructing  genetics  maps  were  genes,  in  which 
alleles  could  be  distinguished  by  visual  examination.  A  new  method  to   22 
distinguish alleles for different proteins was possible after the development of 
biochemical techniques such as gel electrophoresis. These included the scoring 
of blood groups (ABO-series), variants in blood serum proteins and different 
kinds of immunological proteins, such as the equine leukocyte antigen (ELA). 
In the beginning of the 1980’s, 14 marker genes belonging to four different 
linkage groups had been characterized in horse and an additional three markers 
had been assigned to the X chromosome. In 1978, tobiano was the first coat 
color gene to be assigned to a linkage group (Trommershausen-Smith, 1978). 
Four years later Andersson and Sandberg mapped both the chestnut and roan 
loci using 15 blood group and protein loci (Andersson & Sandberg, 1982). 
They were able to map these traits even with this sparse dataset thanks to a 
very  high  number  of  horses,  over  30,000.  In  fact,  that  horse  material  was 
collected from the same biobank used in the present investigations, a repository 
that has now increased to include more than 270,000 horse samples. 
 
The development of dense genome maps was, for many years, hampered by the 
lack of available genetic markers. This problem was solved with the emergence 
of different cloning techniques. In 1992, the first equine microsatellites were 
characterized (Ellegren et al., 1992) and in the same decade, one of the first 
large maps to incorporate microsatellites in horse was produced in Uppsala, 
with over 100 markers assigned to different linkage groups (Lindgren et al., 
1998). Because of the discovery of microsatellites, the 1990’s experienced a 
rapid increase in the number of markers available for linkage studies. Several 
physical maps, such as cytogenic and radiation hybrid maps, were developed as 
a  complement  to  the  genetic  maps.  These  provided  higher  resolution  than 
linkage maps, as they did not rely on recombination. Further, they were also 
invaluable  for  assigning  the  orientation  and  position  of  linkage  groups  to 
different  chromosomes.  In  combination,  the  years  of  effort  from  scientists 
world  wide,  resulted  in  a  high-resolution  map  of  almost  5,000  markers, 
assigned  to  chromosomes,  correctly  orientated  and  supplemented  by 
comparative information from mouse and human. In fact the horse genome 
became one of best characterized among domesticated animals, as reviewed in 
(Chowdhary  &  Raudsepp,  2008).  The  constructed  maps  were  utilized  in 
genome  scans  performed  to  search  for  genes  underlying  various  traits  and 
served as a bank of markers that could be utilized in candidate gene studies, 
phylogenetic studies and parental testing. The maps were also instrumental to 
the  whole  genome  sequencing of  horse by providing a framework for read 
mapping  and  to  ensure  scaffolds  were  assigned  in  the  correct  location  and 
orientation. 
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Sequencing of the horse genome 
In February 2007 the first draft of the horse genome was completed and a 
second version (EqaCab2) was released a few months later. The genome was 
sequenced to approximately 7X coverage using traditional Sanger technologies 
and  a  whole  genome  shotgun  approach.  The  horse  sequenced  was  a 
Thoroughbred mare called Twilight (Wade et al., 2009), selected because of 
her  low  level  of  heterozygosity.  Approximately  96%  of  the  sequence  was 
anchored to chromosomes with a predicted total genome length of 2.43 giga 
bases and many chromosomes showed a high degree of conserved synteny to 
human  chromosomes.  Almost  half  of  the  assembly  constitutes  repetitive 
sequence, mostly long interspersed nuclear elements. The predicted number of 
protein-coding  genes,  20,322,  is  similar  to  predictions  in  other  eutherian 
mammals. Of these annotated genes, 16,617 have predicted human orthologous 
- 15,027 predicted one-to-one orthologous. The gene predictions were verified 
by  transcriptome  analysis  of  eight  equine  tissues  and  88%  of  the  169,073 
predicted exons were expressed (Wade et al., 2009). Most notable among the 
gene families that have undergone paralogous expansion compared to human, 
are keratin genes, which may affect hoof formation and opsin genes, important 
for photoreception. The latter might be important for predator detection. 
 
Approximately 1.2 million SNPs were identified and used to construct a horse 
specific SNP chip. The SNPs are a combination of the heterozygous positions 
identified in Twilight, and those found from a comparison of approximately 
100,000 random reads from each of seven different horse breeds. Two SNP 
chips have now been released to facilitate trait gene mapping in horses. The 
first, EquineSNP50 BeadChip compromised just over 54,000 SNPs and was 
used in paper III of this thesis. An improved version was recently released 
which contains approximately 70,000 SNPs. The degree of within breed LD in 
horse is on average intermediate to dogs and humans, with LD approximately 
five times lower than in dogs and five times higher than in humans. Except for 
in Thoroughbred, LD declines rapidly over the first 50-100 kb in most breeds 
and reaches background levels within 1-2 mega bases (Mb) (McCue et al., 
2012;  Wade  et  al.,  2009).  The  available  horse  genome  sequence,  and  the 
development  of  the  genomic  tools  that  it  facilitated,  have  revolutionized 
molecular genetics research in this species. Both the sequence and the new 
tools have been instrumental in the studies presented in this thesis and will 
continue  to  be  so  in  the  future  -  for  all  scientists  working  with  horse  or 
comparative molecular genetics. 
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Aims of this Thesis 
The  overall  goal  of  this  thesis  was  to  identify  genes  associated  with  three 
distinct  phenotypes  in  horse.  Identification  of  these  genes  would  have 
important implications for horse welfare and could inform breeding decisions. 
Furthermore, mapping trait genes in domestic animals aids in the functional 
annotation of the human genome, as well as the genomes of other economic 
and/or culturally important species. 
 
The specific aims were: 
 
I  To  determine  the  genetic  cause  of  equine  Multiple  Congenital  Ocular 
Anomalies  (MCOA)  syndrome,  to  elucidate  the  debated  mode  of 
inheritance of the disease as well as to estimate penetrance. 
 
II  To investigate if genetic variants in the equine MHC-II region influence 
susceptibility to Insect Bite Hypersensitivity (IBH). 
 
III  To identify loci responsible for the lateral gait “pace” in Icelandic horses 
through whole genome association mapping. 
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Present Studies 
Mutant PMEL causes Multiple Congenital Ocular Anomalies 
syndrome (Papers I and IV) 
Background 
Multiple  Congenital  Ocular  Anomalies  (MCOA)  syndrome  is  a  hereditary 
condition in horse consisting of a wide range of ocular defects (Ramsey et al., 
1999). Most affected horses have a coat color called Silver (Figure 1). In 2006, 
this coat color was shown to be associated with a dominant missense mutation 
in PMEL (Brunberg et al., 2006). Silver horses display a dilution of eumelanin 
(black and brown pigment), into gray or white. This is most noticeable in the 
mane and tail, while the body of the horse becomes slightly diluted in color and 
often  displays  a  dappled  pattern.  The  color  is  especially  desired  in  Rocky 
Mountain horses and Silver horses are thus more frequently used for breeding. 
The consequence is an unusually high frequency of both Silver (approximately 
55% of registered individuals), and MCOA syndrome horses in this breed. The 
documented association between PMEL and Silver gave us the opportunity to 
quantify the degree of linkage between the coat color and MCOA syndrome. In 
a paper published by us in 2008 we used four families of Rocky Mountain 
horses  to  map  the  MCOA  locus  to  a  4.9  Mb  region  on  chromosome  6, 
containing ~190 genes (Andersson et al., 2008). 
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Figure 1. A Silver colored Rocky Mountain Horse. The 
typical shiny white mane and tail, as well as a slightly 
diluted  body  color  with  dapples,  is  seen  in  this 
genetically  black  Silver  colored  horse.  The  horse  has 
also been diagnosed with MCOA. 
 
 
 
 
 
 
 
It has been argued that MCOA syndrome was caused by a recent mutation and 
was restricted to horses that are closely related to the Rocky Mountain Horse, 
however it is now recognized that the mutation is old, at least ~3,000 years 
(Ludwig  et  al.,  2009)  and  present  in  a  diverse  set  of  breeds  including  the 
Icelandic  Horse,  Shetland  Pony,  Exmoor  Pony,  American  Miniature  Horse, 
Belgian  Draft  and  Morgan  Horse,  Kentucky  Mountain  Saddle  Horse  and 
Mountain Pleasure Horse  (Andersson  et al.,  2011;  Komaromy  et al.,  2011; 
Pinard & Basrur, 2011; Plummer & Ramsey, 2011). 
 
Horses with MCOA syndrome can be categorized into two separate groups 
depending  on  disease  severity  and  pedigree  examination  has  suggested  a 
incomplete dominant mode of inheritance (Ewart et al., 2000). The genetic 
study performed by us was in agreement with this hypothesis (Andersson et al., 
2008). Horses that are heterozygous for the disease-causing allele have less 
severe ocular anomalies, mainly displaying peripheral cysts of the iris, ciliary 
body or retina, called the Cyst phenotype. A smaller number of these horses 
also have moderate retinal dysplasia, or retinal detachment, which appears to 
be  an  extension  of  these  cysts.  Homozygous  mutant  horses  present  with 
multiple anomalies and have the so-called MCOA phenotype (Figure 2). They 
encompass all clinical signs included in the Cyst phenotype concurrent with 
iris hypoplasia, retina dysplasia, iridocorneal angle abnormalities, congenital 
cataracts, cornea globosa, iridocorneal adhesions and opacification, as well as 
pupils with a decreased or absent light response and that do not dilate when 
administered mydriatic drugs. A single horse does not necessarily possess all 
of these clinical signs and there are additional defects, which are detected less 
frequently (Andersson et al., 2011; Grahn et al., 2008; Ramsey et al., 1999).   29 
 
Figure 2. Clinical features of MCOA in Icelandic horses homozygous for the PMEL missense 
mutation. A) Multiple iridociliary cysts in the temporal quadrant of the eye. B) A pupil unable to 
dilate  normally  and  cataractous  changes  in  the  lens  contributing  to  visual  impairment.  C)  A 
regional abnormality of the pectinate ligament heralded by a widened, white perilimbal zone 
temporally (red arrows). D) Post-mortem specimen showing multiple demarcation lines in the 
fundus (black arrows) extending towards the optic nerve head and an area where the retina is still 
detached (white arrow). Photos: Björn Ekesten. 
Mutations in PMEL have previously been shown to regulate hypopigmented 
phenotypes, not only in horses, but also in mouse, chicken, zebrafish, dog and 
cattle (Kuehn & Weikard, 2007; Kerje et al., 2004; Kwon et al., 1995). Only 
the zebrafish and dog have reported concurrent ocular anomalies, although in 
different  forms  than  those  observed  in  the  horse  (Schonthaler  et  al.,  2005; 
Gelatt et al., 1981; Dausch et al., 1978). The zebrafish mutant, fading vision, is 
characterized by hypopigmented retinal pigment epithelium (RPE) and most 
likely  because  of  RPE  alteration,  the  outer  segments  of  photoreceptors  are 
strongly reduced in length or completely absent. Interestingly, the retina of 
adults  shows  a  partial  recovery  to  normal  morphology  (Schonthaler  et  al., 
2005). No abnormalities in the other segments of the eye were reported. PMEL 
mutant dogs are called “merles” and typically have blue eyes (Clark et al., 
2006).  Double  merle  dogs  have  an  elevated  frequency  of  ocular  anomalies 
including microthalmia, microcoria, colobomas and increased ocular pressure 
(Gelatt et al., 1981; Dausch et al., 1978). However, not all double merles are 
affected  by  this  pleiotropic  effect  and  surprisingly,  the  proposed  causative 
SINE  element  has  also  been  found  in  a  few  non-merle  dogs  (Clark  et  al.,   30 
2006). In order to study complete loss of function of PMEL, a mouse line with 
inactivated Pmel has recently been created (Hellstrom et al., 2011). This study 
showed that Pmel inactivated mice have a minor visible dilution of the coat 
color but no detectable ocular anomalies. In yet another recent study of the 
biochemical properties of PMEL it was shown that mutations in or near the 
transmembrane domain (TMD) of PMEL, like the Silver mutation in horse, 
alter  the  capacity  of  this  region  to  self-associate  (Watt  et  al.,  2011).  The 
mutations alters fibril formation into a more compact structure and this in turn 
leads to severe pigment loss. In chicken, the effect of the mutation causing the 
Dominant white phenotype was shown to be similar to that in horse, however 
ocular examination of these birds could not identify any structural changes or 
other eye anomalies (Karlsson et al., 2009). The aim of this project was to 
identify the causative mutation for MCOA syndrome and to establish if PMEL 
is the gene responsible; a debated theory given that no ocular anomalies are 
seen in most of the PMEL mutant species, including the null mouse. 
 
Results and discussion 
In paper I, we extended our previous MCOA syndrome study to include 465 
horses (Cyst phenotype, n= 246; MCOA phenotype, n= 83) from four different 
breeds  including  Rocky  Mountain  horses,  American  Miniature  horses, 
Kentucky  Mountain  Saddle  horses,  and  Icelandic  horses.  IBD  mapping 
pinpointed a 208 kb genomic interval harboring the MCOA mutation (Table 1). 
The identified interval is gene-dense, harboring 15 genes. Several of these are 
known,  or  proposed  to  be,  involved  in  ocular  development  or  disease.  In 
addition,  the  study  verified  that  the  disease  is  inherited  as  an  incompletely 
dominant  trait  and  that  the  two  distinct  phenotypic  categories,  Cyst  and 
MCOA, are caused by one and two copies of the mutant allele, respectively 
(p= 2.20x10
-16). We were unable to detect clinical signs of MCOA syndrome in 
six percent of the genetically characterized heterozygous horses. This might be 
due to modifier loci or due to our inability to detect small cysts if positioned 
just posterior of the iris. Importantly, many of these non-penetrant horses have 
produced affected offspring when crossed with non-carriers. 
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Table 1. Phased data of 13 markers defines a 208 kb IBD haplotype. Six distinct haplotypes were identified in the four analyzed breeds. The minimal IBD region 
is marked in light grey and the haplotypes crucial for excluding genes marked in dark grey. 
Haplotype  No of 
chr 
MS1  N1  MS14  PMEL     
-ex11 
MS3  8345  TKY284  837
7 
MS13  SMARCC
-int24 
SMARCC
-int19 
8453  8475  Breed 
A  355  269  T  247  T  233  C  177 or 175  C  222  G  G  A  T  RH, KY 
B  12  263  G  247  T  233  C  177  C  222  G  G  G  A  RH, KY 
C.1  10  263  G  247  T  233  C  177  C  222  G  G  A  A  MINI 
D.1  21  263  G  247  T  231  C  177  C  222  G  G  G  A  IS 
D.2  1  263  G  247  T  231  C  177  C  222  G  T  G  A  IS 
C.2  10  263  G  247  T  233  C  177  C  222  A  T  G  A  MINI 
Position     0  33  50  58  115  118  161  180  227  240  242  297  360    
No of chr= The number of chromosomes containing of each haplotype. RH= Rocky Mountain Horse, KY= Kentucky Mountain Horse, MINI= American Miniature Horse, IS= 
Icelandic Horse. Position= The chromosome position of marker MS1 is 73,607,795 and is here set as the reference point zero (0). The distances to the following markers are given in 
kb. 
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In paper IV we used Illumina TruSeq technology to sequence the entire IBD 
region  in  five  homozygous  MCOA  horses  from  three  different  breeds,  one 
horse with the heterozygous Cyst phenotype and four healthy controls. In an 
attempt to minimize the number of candidate mutations, we carefully selected 
healthy horses with haplotypes as similar as possible to the MCOA haplotype 
in conjunction with cases representing different breeds. After filtering out all 
SNPs that did not follow the correct mode of inheritance, i.e. horses with the 
MCOA  phenotype  homozygous  for  one  allele,  Cyst  phenotype  horse 
heterozygous, unaffected horses homozygous for the opposite allele, only two 
SNPs remained. Both of these SNPs are positioned within the PMEL gene, 
demonstrating that this gene is in fact important for ocular development or at 
least  has  the  ability  to  change  eye  structure  into  a  pathologic  form  when 
mutated. One of the identified SNPs is intronic and in an unconstrained region 
according  to  29  mammals  conservation  scores.  The  other  SNP  however 
introduces  an  amino  acid  change  in  the  cytoplasmic  religion  of  PMEL 
(Arg625Cys). 
 
The molecular effects of this missense mutation have recently been studied in 
detail (Watt et al., 2011). Most importantly, the mutation is positioned very 
close to the TMD and whereas the wild type TMD is not able to oligomerize, 
human PMEL with an introduced mutation analogues to the horse mutation 
(hPMEL
R625C) gains this function and can readily self oligomerize. The horse 
mutation causes a replacement of the middle of three consecutive arginines to a 
cysteine. The new oligomerization ability of the TMD was therefore suggested 
to be a consequence of decreased electrostatic repulsion between the adjacent 
basic RRR motifs through the removal of a positive charge. Upon maturation 
of  profibrils  into  elongated  fibrillar  sheets,  hPMEL
R625C  show  marked 
differences to wild type. In mouse melanocyte cell lines expressing the latter, 
most  stage  III  and  IV  melanosomes  were  densely  pigmented.  In  cells 
expressing mutant form, there was less space between the fibrils and the sheets 
appeared abnormally tightly packed. Importantly, and probably because of this 
arrangement,  the  organelles  seemed  to  lack  pigmentation.  These  findings 
suggest that either the fibrils were no longer capable of binding to melanins or 
that melanin production was somehow inhibited. Electron microscopy analysis 
revealed that cells expressing mutant PMEL were hypopigmented, harbored 
fewer pigmented melanosomes and were enriched in early stage melanosomes 
(Watt et al., 2011). This data reveals a clear functional effect of the coding 
SNP  and  together  with  our  genetic  finding,  demonstrates  that  the  missense 
mutation in exon 11 of PMEL causes MCOA syndrome in horse. 
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Future prospects and practical implications 
Why  do  changes  in  PMEL  fibrilliar  sheet  formation  cause  such  dramatic 
morphological alternations to the horse eye? Does PMEL have other functions 
besides those of melanin processing? The anomalies seen in eyes of horses 
may suggest alterations in cellular differentiation and/or migration. PMEL is 
known to be expressed in two different kinds of pigment cells in the eye, the 
neural ectoderm derived retina- iris- and ciliary body pigmented epithelia and 
in neural crest derived uveal melanocytes distributed in the middle layer of the 
eye (choroid, iris and ciliary body) (Hu et al., 2008). The purpose of these cells 
are  numerous,  so  if  the  abnormal  sheet  formation  severely  encumbers  cell 
capacities, severe morphologic and functional changes to the eyes would not be 
surprising. RPE provides metabolic support for the retina, is involved in the 
phagocytosis of the constantly shedding photoreceptor outer segment, converts 
and stores retinoid, absorbs scattered light, facilitates transportation of ions, 
fluid and nutrition and secrets several growth factors (Strauss, 2005). Less is 
known  about  the  other  two  pigmented  epithelia  but  the  ciliary  pigment 
epithelium is important for the production of aqueous humor whilst the iris 
pigment  epithelium  is  important  for  dilation  of  the  pupil.  The  uveal 
melanocytes produce extracellular matrix degrading enzymes as well as growth 
factors,  such  as  vascular  endothelial  growth  factor,  which  may  control  the 
blood circulation of the eye (Hu et al., 2002). A first step in the continued 
analysis of the horse mutation may be to use in situ mRNA hybridization and 
PMEL  protein  immunohistochemistry  in  mutant  and  normal  eye  tissue  to 
compare  if  either  the  expression  levels  and/or  localizations  are  altered  in 
homozygous  mutants.  Timing  might  then  be  of  great  importance  as  it  is 
possible  that  PMEL  expression  influences  development  during  a  short  time 
window  and  therefore  it  is  necessary  to  analyze  tissue  from  the  exact 
developmental stage in order to see differences in expression. 
 
Another interesting question is why some species present ocular alterations and 
some do not? This is likely because of the genetic background, for example; 
we  know  that  PMEL  expression  is  microphthalmia-associated  transcription 
factor (Mitf) dependent (Baxter & Pavan, 2003). An interesting study would be 
to quantify the ocular anomalies, since they vary significantly between affected 
individuals, and to then investigate if this has a correlation to genotypes at 
other coat color loci, such as the Extension and Agouti loci. The same would 
apply  to  the  genetically  characterized  heterozygous  horses  that  were  not 
diagnosed with any ocular anomalies. Perhaps the most powerful approach to 
address the function of the mutation is by the generation of a knock-in mouse. 
This would provide an opportunity to monitor PMEL expression during eye   34 
embryological development and further give us the opportunity to investigate 
the effect of mutant PMEL on different color backgrounds. 
 
The risk of MCOA syndrome and its link to the silver mutation should be taken 
into consideration in breeding decisions. Horses with the MCOA phenotype are 
at  particular  risk  of  having  impaired  vision,  and  difficulties  in  adapting  to 
changing light conditions are probably a common phenomenon in these horses. 
Some  individuals  have  more  severe  impairment  of  their  vision,  causing 
abnormal  behavior  and  an  inability  to  perform.  Breeding  PMEL  mutation 
carriers  only  to  known  non-carriers  would  practically  eliminate  the  risk  of 
producing  horses  with  the  vision  threatening  abnormalities  caused  by  this 
syndrome.  The  PMEL  mutation  does  not  have  an  obvious  effect  on 
phenomelanin  (red  and  yellow  pigment),  making  it  virtually  impossible  to 
detect phenotypically in horses lacking dark pigment, for example chestnuts, 
white grays, palominos, pearl- and champagne-colored horses. These horses 
must be genotyped in order to determine their carrier status. 
 
Variation in the MHC-II region increases the susceptibility to 
Insect Bite Hypersensitivity (Paper II) 
Background 
Insect  Bite  Hypersensitivity  (IBH)  is  the  most  common  allergic  disease  in 
horses and affects numerous breeds worldwide. It is generally caused by an 
allergic IgE mediated type I hypersensitivity reaction against proteins in the 
saliva of various species of the biting midges, Culicoides ssp (Schaffartzik et 
al., 2012; Mellor & McCraig, 1974; Ishihara, 1957). The prevalence of IBH 
among Icelandic horses born in Sweden is approximately 8% (Eriksson et al., 
2008). In contrast, the prevalence is sometimes as high as 26–35% in horses 
exported from Iceland, most likely because Culicoides does not exist in Iceland 
and  thus  these  horses  have  not  encountered  the  antigen  in  early  life 
(Schaffartzik et al., 2012; Bjornsdottir et al., 2006; Brostrom et al., 1987). This 
theory  was  strengthen  by  a  recent  study  performed  on  horses  exported  as 
weanlings which revealed that if a horse is exposed to allergens at the age of 7-
10 months, they do not develop IBH at a higher frequency than horses born in 
Europe. 
 
IBH is clearly seasonal, determined by the activity of insects and is classed as a 
chronic disease. Symptoms include intensely pruritic lesions, urticaria, oedema 
and papules  (Figure 3). These are usually most prominent along the dorsal   35 
midline, in particular the tail base, mane, head, withers and rump (Schaffartzik 
et al., 2012). Horses suffering from IBH that have been left unattended can 
easily be recognized by the almost complete loss of hair from the mane and tail 
and  continuous  scratching  may  cause  open  wounds.  Secondary  symptoms 
include lichenification, crusts and scaling (Brostrom et al., 1987). The ability 
of  affected  horses  to  graze  might  be  impaired  due  to  constant  itching  and 
rubbing. 
 
Figure 3. Icelandic horse affected with IBH. 
This  10  year-old  gelding,  imported  to 
Sweden  from  Iceland,  has  scratched  away 
most of its mane and tail as a consequence of 
IBH. These photos, taken at a late, chronic, 
stage of the disease, show the formation of 
transverse ridges and folds produced by the 
prolonged  self-induced  skin  trauma. 
Secondary thickening of the skin gives this 
animal  a  leathery  bark-like  appearance 
(lichenification). Source: Hans Broström. 
We have estimated the heritability of IBH for Icelandic horses born in Sweden 
at  0.08  on  the  visible  scale  and  0.33  on  an  underlying,  continuous  scale 
(Eriksson  et  al.,  2008).  Similar  estimates  have  been  reported  for  Shetland 
ponies and Friesian horses (Schurink et al., 2011; Schurink et al., 2009). In the 
study  presented  in  paper  II,  we  decided  to  investigate  the  major 
histocompatibility complexes (MHC) II because: i) certain human leukocyte 
antigen (HLA) class II variants are associated with an increased risk of atopic 
dermatitis in man, a disease that partially resembles equine IBH (Kiyohara et 
al., 2008; Saeki et al., 1995); ii) histopathological analysis of IBH affected skin 
reveals an increased number of MHC-II positive cells, presumably Langerhans 
cells  and  iii)  two  studies  have  shown  serologically  that  certain  equine 
leukocyte antigen (ELA) class II specificities are linked to IBH susceptibility 
(Lazary et al., 1994; Marti et al., 1992; Halldorsdottir et al., 1991). We wanted 
to confirm these associations because the larger of these studies did not seem to 
consider the relationship among horses sampled and therefore the result might 
be influenced by population stratification. Furthermore, recent investigations 
on the MHC class II region, showed that multiple microsatellite haplotypes 
could be associated with a single serotype (Tseng et al., 2010) and so DNA 
genotyping therefore provides better resolution than the earlier methodologies. 
The ELA class II region in horse is positioned on chromosome 20 and harbors 
three DQA loci, two DQB loci and three DRB loci (Tseng et al., 2010). Only 
one copy of the DRA locus is present, however contrary to many other species,   36 
this gene is polymorphic in the domestic horse, with at least four different 
alleles  identified  (Brown  et  al.,  2004;  Albright-Fraser  et  al.,  1996;  Bailey, 
1994). 
 
Results and discussion 
In an effort to establish if specific ELA-II alleles are associated with IBH status 
we tested 94 IBH affected and 93 unaffected Icelandic horses. These horses 
were paternal half-sibs sired by 42 different stallions. The average number of 
offspring per stallion was 4.5. In order to standardize the environmental effect 
we only included horses born in Sweden. Also, these horses had previously 
been genotyped on the Illumina Equine SNP50 BeadChip, making it possible 
to ensure that our study did not suffer from the effects of stratification. The 
result  was  subsequently  followed  up  in  a  second,  independent  population 
consisting of 106 unaffected and 80 IBH-affected Exmoor ponies. All horses 
were genotyped at four microsatellite markers positioned within the MHC class 
II region and were sequenced for the highly polymorphic exons two from DRA 
and DRB3 respectively. 
 
Marker COR112 was clearly associated with IBH status (Table 2) with allele 
274 enriched in cases (f= 0.22) compared to controls (f= 0.06), odds ratio 4.19 
(95% CI= 2.00-9.44, p= 2.34x10
-5). In the Exmoor ponies, COR112 allele 274 
was likewise associated (praw= 0.043) but was much more common, with a 
frequency of 0.60 in affected horses compared to 0.50 in healthy ponies. Thirty 
SNPs  and  two  indels,  which  after  phasing  constitute  eight  different  alleles, 
were identified in the DRB3 gene. The frequency of DRB3 allele 1.2 was three 
times  higher  in  affected  Icelandic  horses  compared  to  controls  and  was 
significantly  associated  with  IBH  status  (praw=  0.004,  OR=  3.60). 
Unexpectedly, we also found that DRB3 allele 1 was possibly protective (praw= 
0.015) in Icelandic horses. It was present at a frequency of 0.51 in healthy 
horses but only 0.37 in affected horses, giving an odds ratio of 0.58 (95% CI= 
0.38-0.91). However, these two DRB3 alleles differ only by one intronic SNP 
and therefore  likely  produce  the  same  peptide.  Hence, the associations that 
these alleles display are probably not due to their phenotypic effect but rather 
due to LD with causal variants. Further, this marker was not associated to IBH 
status in Exmoor ponies. 
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Table 2. Association results between ELA markers and IBH in Icelandic horses. 
               IBH     Healthy          
Marker  Position  
(bp) 
p-value 
(2xN) 
df   Ad  n  p(Ad)     n  p(Ad)  p-values 
(2x2) 
OR  95% OR 
DRA  32690939  0.025  2  0201  94  0.17     91  0.08  0.012  2.28  1.15-4.71 
COR112  33282436  0.001  5  274  86  0.22     87  0.06  2.34x10
-5  4.19  2.00-9.44 
DRB3  33364480  0.008  3  1.2  91  0.13     91  0.04  0.004  3.60  1.45-10.2 
COR113  33480825  0.271  3  282  89  0.14     86  0.07  0.037  2.17  1.01-4.93 
UM011  33510120  0.151  4  180  90  0.13     86  0.06  0.033  2.25  1.02-5.26 
COR114  33516304  0.354  4  259  89  0.13     89  0.08  0.229  1.61  0.77-3.45 
df= degrees of freedom, Ad= allele most strongly associated with disease, p(!")= frequency of Ad and OR= 
odds ratios 
 
Interesting, when we combined microsatellite and sequencing data in order to 
investigate the pattern of homozygosity throughout the MHC class II region we 
could  conclude  that  affected  and  healthy  horses  had  different  degrees  of 
homozygosity.  In  Icelandic  horses,  0.13  of  affected  individuals  were 
homozygous, compared to only 0.04 of the control horses. Homozygous horses 
were  more  commonly  observed  among  the  Exmoor  Pony  samples,  with 
frequencies of 0.30 and 0.15 respectively. A Cochran-Mantel-Haenszel test, 
which  combines  data  from  both  breeds,  showed  that  homozygosity  in  the 
region confers a higher risk of developing disease, with an odds ratio of 2.67 
(p= 0.0013, 95% CI= 1.22-4.66). The data presented in this study confirms the 
association of ELA alleles to IBH reported earlier and presents a novel link 
between homozygosity in the MHC-II region and disease frequency. It is still 
unclear what the causal variants are or how homozygosity influences disease 
susceptibility. Each requires further research. 
 
Future prospects and practical implications 
It  would  be  of  great  interest  to  pinpoint  the  causal  ELA  variant(s)  and  to 
understand their role(s) in disease manifestation. Unfortunately fine mapping is 
made somewhat difficult by two major aspects: i) the horse MHC-II region is 
not  yet  fully  characterized  and,  like  humans,  many  large  allele  specific 
duplications are likely to exist and ii) to prove causality is often difficult in 
complex diseases, where a simple one-to-one relationship between genotype 
and phenotype does not exist. Potential causative variants may also be present 
in healthy individuals that have not developed the disease due to other genetic 
or  environmental  factors.  However,  further  fine  mapping  through  the 
examination of allele frequency differences in a larger horse material and using 
a  more  dense  marker  set  should  certainly  be  possible  considering  i)  the   38 
associated region presented here is not yet well defined as a clear 3’ border has 
not been established and ii) the examined region is large, with the two most 
distant markers, DRA and COR114, positioned 825 kb apart. Subsequent re-
sequencing of selected individuals can be exploited to catalogue all potential 
causative mutants and subsequent characterization, including examination of 
variant  conservation  scores  and  qPCRs,  may  isolate  those  mutations  most 
likely to play a role in IBH susceptibility. 
 
Genes  outside  the  MHC-II  region  most  likely  also  contribute  to  disease 
susceptibility.  We  have  performed  one  GWAS  using  104  healthy  and  105 
affected Icelandic horses, however could not detect any SNPs reaching genome 
wide significance. This was likely due to a lack of power because of small 
effect sizes relative to the number of genotyped subjects. The marker density 
was probably also a limiting factor. We utilized the Illumina Equine SNP50 
BeadChip but only approximately 38,400 SNPs remained both after quality 
control filtering and excluding SNPs with a minor allele frequency of 0.05. 
Recently an IBH susceptibility GWAS was performed in Shetland ponies, and 
whilst some promising chromosomal regions were shown to be associated to 
disease, it was not clear if these reached genome wide significance (Schurink et 
al., 2012). As a collaborative effort we are now planning a meta-analysis in an 
effort to increase our chances of find genes with smaller effects. The best way 
of  overcoming  limitations  in  marker  densities  is  to  do  whole  genome  re-
sequencing.  This  methodology  has  the  advantage  of  providing  data  for 
mapping,  fine  mapping  and  the  identification  of  potential  causative 
polymorphic sites in one single experiment. 
 
To date, our advice to horse breeders is to limit the extent of inbreeding as this 
might influence IBH susceptibility by increasing the levels of homozygosity in 
the MHC-II region. However, we do not recommend the direct testing of these 
markers with the aim of minimizing the frequency of the 214-allele and there 
are many reasons for this. First and foremost, we do not yet know the causative 
variant  and  the  degree  of  LD  between  this  and  the  COR112  marker.  This 
means that inherently, a number of horses will be incorrectly diagnosed either 
as carriers or non-carriers. Second, we do not yet know the effect size of the 
mutation, and so do not know how a COR112 breeding strategy would affect 
the  long-term  health  of  the  breed.  Each  of  these  test  factors  needs  to  be 
explained  to  horse owners carefully,  so  as  to avoid  an  “over-belief”  in  the 
MCH-II  results.  These  results,  if  used  prematurely  in  breeding  could 
potentially have undesirable side effects. 
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Identification of the first Gait locus in horse (Paper III) 
Background 
Most horse breeds can only perform the three basic gaits; “walk”, “trot” and 
“canter”. However, some breeds are called “gaited” as they are able to perform 
the  lateral  two-beat  gait  “pace”  (Figure  4a),  and/or  different  varieties  of 
ambling  gaits.  The  ambling  gait  may  vary  slightly  between  breeds  but  is 
always  characterized  by  a  four-beat  footfall,  which  makes  it  particularly 
smooth and comfortable for the rider. The variable parameter is primarily if 
there is an exactly even timing between footfall patterns, as in the Icelandic 
horse  gait “tölt”,  or  if  there  is  a  slight  delay,  leading  to  either  a  lateral  or 
diagonal  coupling  of  the  legs.  There  are  over  60  gaited  breeds  worldwide 
(Hendricks, 1995) and these are more common in America and Asia than in 
Europe. Gaitedness has been under strong selection in many breeds and has 
also been the basis for the formation of new breeds. In principle, all Icelandic 
horses can tölt but not all of them have the ability to pace. Thus horses of this 
breed are categorized as being either four-gaited (walk, trot, canter, tölt) or 
five-gaited (walk, trot, canter, tölt and pace). The segregation of this trait made 
it possible to investigate the underlying genetic cause, with the potential of 
revealing interesting biological insights into the regulation of locomotion. The 
heritability  for  pace  has  been  estimated  at  0.60  in  Icelandic  horses 
(Albertsdottir et al., 2011), and a recessive mode of inheritance had previously 
been suggested in Standardbred horses (Cothran et al., 1987). 
 
Most quadrupeds trot (Figure 4b) and even biped humans swing their arms in 
simultaneous motion with their diagonal leg. However some species (such as 
camels and llama) move in pace instead of trot, whilst yet others perform an 
ambling gait (such as giraffe and elephant). Neuronal circuits in the spinal cord 
generate  the  rhythmic  and  coordinated  neural  output  required  for  limb 
movement  (Goulding,  2009;  Nishimaru  &  Kakizaki,  2009).  These  neuronal 
circuits are collectively referred to as central pattern generators (CPGs) and 
have been shown to function even without external input (sensory feedback 
and input from the brain). CPGs coordinate the spatial and temporal activity of 
the joint muscles from all four limbs and also regulate the speed and stability 
of gait rhythm. Different neurons in the CPG can be characterized based on 
their location, projections, morphology, neurotransmitters and more recently, 
on  their  marker  gene  expression  pattern  profile,  such  as  cell  type  specific 
transcription factors (Kullander, 2005). Although several specific populations 
of  neurons  have  been  identified  to  date,  substantial  research  is  required  to 
elucidate  their  function  and  relative  importance  in  the  pattern  generating   40 
mechanism. Here, inhibitory neurons are just as important as their excitatory 
counterparts for the generation of alternating movements, as flexion can only 
occur in combination with a relaxation of the antagonistic muscles. While over 
one  thousand  genes  have  been  linked  to  uncoordinated  movements  in  C. 
elegans, and more than two hundred mutant lines with walking defects have 
been identified in Drosophila (Kullander, 2005) many fewer genes have been 
identified in mouse. Two mouse lines with spectacular locomotive defects are 
the EPH receptor A4 null mouse and its ligand pheno-copy, the null ephrin-B3 
mouse; both of which display a rabbit like parallel-coupled gait (Kullander et 
al.  2003;  Dottori  et  al.  1998).  A  complete  switch  from  alternating  to 
synchronous drug induced fictive locomotion can also be identified in mice 
with mutant netrin-1 (Rabe et al. 2009). All three of these genes are expressed 
in commissural neurons, establishing an important role for this cell type in left 
and right synchronization. 
 
Results and discussion 
In paper III we further exploited the available Illumina Equine SNP50chip data 
from 209 Icelandic horses by correlating this to the phenotypic description of 
each horses’ gait. A questionnaire was sent to all owners of genotyped animals 
and 30 replied that their horse was four-gaited and 40 reported to have a five-
gaited  (pacing)  horse.  A  GWAS  revealed  a  single  highly  significant  SNP 
positioned on chromosome 23. The association was strongest when a recessive 
mode of inheritance for pace was considered (praw= 1.7 x 10
-9, EMP2= 2.0 x 
10
-4, Figure 4c). The result was verified in an independent sample set of 190 
horses (p= 2.4x10
-14, Table 3). It is worth noting that of the horses classified as 
four-gaited, as many as 31% are homozygous mutant and should, according to 
the model, be able to pace. A proportion of this discrepancy is likely due to the 
use of phenotypic categorization from breeding field tests scores. Pace is a very 
demanding gait, and there are many factors influencing why a five-gaited horse 
presents as four-gaited on the day of evaluation. These include the level of 
experience for both horse and rider and the mental and physical condition of 
the  animal  at  the  time.  Even  so,  the  presence  of  modifying  loci  cannot  be 
excluded.  Another  interesting  observation  is  the  low  number  of  wild  type 
homozygots (Table 3). This is in concordance with the GWAS and reflects the 
fact that Icelandic horse breeders less often cross two four-gaited horses to 
each other.   41 
 
Figure 4. Identification of a DMRT3 mutation in horses. A) A pacing Icelandic horse, fore and 
hind legs on the same side of the body are synchronized. B) A trotting Icelandic horse, the fore 
and hind legs on the opposite side of the body are synchronized diagonally. C) Genome-wide 
association analysis revealed a highly significant association between the ability to pace and SNP 
BIEC2_620109 on horse chromosome 23 (praw=1.7 x 10
-9, EMP2 = 2.0 x 10
-4). D) The 684 kb 
genomic interval associated with the Gait locus. The shaded region defines the minimum IBD 
region (438 kb). 
We re-sequenced the whole genome of one four-gaited and one five-gaited 
horse and extracted reads mapping to an established 438 kb IBD region (Figure 
4d). We identified 65 variants unique to the Gait haplotype, including a very 
good candidate mutation; a cysteine to adenine transversion in exon two of the 
transcription factor DMRT3 creating a premature stop codon. The mutation is 
predicted to cause a truncated protein lacking the last 174 amino acids, which 
is ~40% of the entire sequence and would result in the loss of many highly 
conserved residues. The mutation was genotyped in a panel of gaited and non-
gaited  horse  breeds  and  the  results  showed  remarkable  concordance  to  the 
alternative gait phenotype (Table 3). Nearly all individuals from gaited breeds 
were  homozygous  mutant,  regardless  of  whether  their  alternate  gait  is 
characterized  by  the  lateral  pace,  regular  beat  ambling  or  lateral/diagonal 
couplets ambling. Thus, when considering the data across breeds, the DMRT3 
mutation is permissive for the ability to perform these alternate gaits. Training 
is probably one important factor affecting the gait phenotype but other loci that 
regulate  and  fine-tune  the  pattern  of  locomotion  are  likely  to  exist. 
Interestingly, the mutation was also found at high frequencies in horses used 
for harness racing and we were able to connect this to racing performance. 
First, we performed a blind study on 61 Standardbred horses in training at a 
race-camp near Uppsala. Two horses had difficulties in sustaining trot at high   42 
speed.  Genotyping  revealed  that  these  two  were  heterozygous,  while  the 
remaining 59 horses were homozygous mutant (p= 0.0005). Thus the mutation 
enables horses to trot at high speed without breaking into gallop, the natural 
gait for horses at high speed. Further, in a population-based investigation we 
could  conclude  that  homozygous  mutant  horses  have  on  average  superior 
breeding values (best linear unbiased prediction, BLUP- values) and higher 
earnings. 
 
 
Table 3. DMRT3 genotype frequencies among horse populations. 
1Wild type. 
2These do not include the horses included in the initial GWAS and therefore provides a replication 
of the original highly significant association. 
 
 
Breed  Number  CC
1  CA  AA 
A. Gaited horses         
Icelandic horses
2             
Four-gaited  124  0.02  0.67  0.31 
Five-gaited  66  0.00  0.02  0.98 
Random sample  162  0.00  0.22  0.78 
              
Other gaited horses             
Kentucky Mountain Saddle Horse   22  0.00  0.09  0.91 
Missouri Fox Trotter  40  0.00  0.00  1.00 
Paso Fino  45  0.00  0.00  1.00 
Peruvian Paso  19  0.00  0.00  1.00 
Rocky Mountain Horse  17  0.00  0.00  1.00 
Tennessee Walking Horse  33  0.00  0.03  0.97 
              
B. Non-gaited horses             
Arabian Horse  18  1.00  0.00  0.00 
Gotland Pony  28  1.00  0.00  0.00 
North-Swedish Draft Horse  31  1.00  0.00  0.00 
Przewalski's Horse  6  1.00  0.00  0.00 
Shetland Pony  20  1.00  0.00  0.00 
Swedish Ardennes  22  1.00  0.00  0.00 
Swedish Warmblood  64  1.00  0.00  0.00 
Thoroughbred  29  1.00  0.00  0.00 
              
C. Horses bred for harness racing             
Standardbred, trotter (Sweden)  270  0.00  0.06  0.94 
Standardbred, trotter (USA)  57  0.00  0.00  1.00 
Standardbred, pacer (USA)  40  0.00  0.00  1.00 
French Trotter (France)  47  0.06  0.34  0.60   43 
We  studied  the  functional  effects  of  the  mutation  (Figure  5).  First,  the 
truncated DMRT3 mRNA is not subjected to nonsense-mediated decay. This is 
in agreement with studies showing that this process primarily effects mRNA 
with mutations prior to the last intron (Culbertson & Leeds, 2003). Next, we 
used  EMSA  and  confirmed  that  the  protein  still  retains  its  DNA  binding 
capacity. It may therefore be a dominant negative mutation with normal DNA-
binding  properties  but  with  defective  interaction  with  other  proteins.  We 
tagged  the  protein  with  GPF  and  expressed  the  construct  in  human  glioma 
U251  cells.  Both  mutant  and  wild  type  protein  localized  to  the  nucleus. 
Furthermore, in situ mRNA hybridization in horse spinal cord tissue sections 
established that both mutant and wild type DMRT3 is expressed in a small 
population of neurons located in the ventral horn and around the central canal. 
 
Figure  5.  Functional  characterization  of  the  horse  DMRT3  mutation.  A)  mRNA  in  situ 
hybridization of tissue sections from the lumbar spinal cord of wild type (CC, left) and mutant 
(AA, right) horse. Arrows mark neurons with DMRT3 expression. B) Transfection experiments in 
human glioma U251 cells. eGFP-DMRT3 proteins (green) corresponding to the wild type and 
mutant  forms  coincides  with  anti-DMRT3  antibody  labeling  (purple),  both  showing  nuclear 
localization (co-localization with DAPI, blue). C) EMSA using an oligonucleotide containing a 
DMRT3-binding motif and in vitro-translated myc-tagged DMRT3 wild type and mutant proteins. 
Scale bars: 1 mm (a), 100 µm (a, close-up), 10 µm (b).   44 
A  Dmrt3  knockout  mouse  model  had  previously  been  generated  which 
displayed  shorter  lifespan  compared  to  their  wild  type  counterpart  and 
occasionally male sexual development abnormalities (Ahituv et al., 2007). We 
further characterized this mouse model with a focus on locomotion and spinal 
cord  neuron  development  and  also  investigated  Dmrt3  expression  during 
different developmental stages in wild type mice. The result led us to conclude 
an  important  role  for  Dmrt3  in  gait  control.  The  major  outcomes  of  the 
investigations were: 
 
I  Already in E12.5, the gene is expressed in a small subset of commissural 
neurons i.e. those that cross the spinal cord midline. These neurons: 
i.  belong to the dI6 interneurons 
ii.  are inhibitory 
iii.  connect to motor neurons 
 
II  The dI6 population is of similar size in wild type and null mice. However, 
there is a 58% increase in Wilms Tumor 1 (WT1) positive neurons, which 
also belong to dI6, and fewer commissural neurons in null mice.  
 
III  Central pattern generated output, as analyzed in isolated neonatal spinal 
cords  using  drug  induced  fictive  locomotion,  revealed  strikingly 
uncoordinated and irregular rhythm signaling in null mice. 
 
IV  In air stepping experiments at postnatal day (P) 1 and P4, alternating hind 
limb  movements  were  almost  completely  absent  in  Dmrt3  null  mice. 
Alternating movements were regularly seen in wild type mice as well as in 
the front legs of null mice. 
 
V  When  challenged  in  water,  knockout  mice  displayed  decreased  swim 
duration and twitching movements rarely observed in wild type. 
 
VI  Null mice had difficulties in sustaining the same high speed as wild type 
mice when placed on a treadmill. 
 
VII On  the  treadmill,  there  were  several  significant  deviations  in  gait 
parameters suggesting that at slower velocities null mice take longer strides. 
 
In paper III, we give abundant evidence that the DMRT3 nonsense mutation 
causes the gait phenotype in horses and that we have identified a new molecule 
important for the control of locomotion. The loss of Dmrt3 in mouse might   45 
result  in  a  more  permissive  and  flexible  state  of  the  locomotive  circuit. 
Likewise, horses with the ability to perform alternate gaits should benefit from 
a loosely hardwired neuronal circuit and indeed, all such tested horses carry the 
DMRT3 nonsense mutation. Moreover, the DMRT3 mutation has accumulated 
in harness race horses for which the transition from trot to gallop leads to race 
disqualification. The clear dichotomous distribution of the mutation in different 
breeds is likely due to the fact that the mutation has unfavorable effects for 
some  purposes  such  as  gallop  racing,  dressage,  show  jumping  and  heavy 
drafting. Supporting this, we show that Icelandic horses carrying at least one 
wild type allele have superior breeding field test scores for trot and canter. 
Further, Standardbred trotters, most of which are homozygous mutant, often 
have difficulties in canter, hindering their performance in dressage and show 
jumping. 
 
Future prospects and practical implications 
The discovered connection between the DMRT3 gene and locomotion opens a 
whole  new  field  of  research  opportunities.  First,  which  gene  activities  are 
dependent  on  this  transcription  factor?  ChipSeq  (chromatin 
immunoprecipitation in combination with massive parallel DNA sequencing) 
from wt as well as transcriptome comparisons between wt and knockout mice 
would give interesting information about target genes and how the DMRT3 
mutation affects transcription levels. Also, we know that the truncated DMRT3 
retains  its  DNA  binding  capacities,  but  we  do  not  know  if  it  can  still 
activate/repress  transcription.  We  are  currently  conducting  luciferase 
experiments  in  order  to  investigate  this.  Further,  the  horse  mutation  is 
interesting since it has an effect in heterozygotes. The generation of a knock-in 
mouse could give us the opportunity to further characterize the effect of the 
protein truncation, especially its dominant negative effect. In the null mouse, it 
is quite interesting that we observe such a dramatic phenotype in spinal cord 
signaling during development, but a milder phenotype in adults. There seems 
to  be  a  compensatory  mechanism,  something  that  is  also  suggested  by  the 
observed  expansion  of  the  WT
  positive  cells  and  an  increase  in  Dmrt1 
expression. The generation of a conditional knockout would answer important 
questions regarding the DMRT3
+ subset of cells without prior establishment of 
compensatory effects during embryonic development.  
 
In a comparative genetic effort, we have started to investigate if the DMRT3 
gene is inactivated in other species not moving in a regular trot. Furthermore, 
mutations in DMRT3 are likely to exist in humans and might lead to defects in   46 
synchronization of limb movement or other diseases connected to locomotion. 
Novel DMRT3 mutations might also be found in horses bred for other purposes 
and sequencing of coding regions and conserved elements could be performed 
in a number of highly specialized breeds. 
 
When  did  the  horse  DMRT3  nonsense  mutation  first  arise  and  how  has  it 
spread  to  the  worldwide  distribution  seen  today?  The  mutation  may  have 
occurred  for  the  first  time  in  a  foal  living  among  the  big  horse  herds  of 
Mongolia and China and then spread to Europe and finally reached North and 
South  America  with  the  settlers.  Extremely  few  gaited  horses  are  found  in 
Africa and these originate from Mongolian and American Saddle bred horses 
(Hendricks,  1995).  We  are  currently  testing  this  hypothesis  by  first  deep 
sequencing the established IBD region in 16 diverse breeds. The distribution of 
mutations  may  serve  to  tell  us  something  about  the  relatedness  of  the 
haplotypes but will also identify polymorphic sites. These variants can be used 
in a larger worldwide haplotype analysis of gaited and none-gaited breeds. We 
are also genotyping the mutation in ancient samples. 
 
Important  modifier  loci  are  likely  to  exist.  As  a  first  step  toward  their 
identification, we are planning whole genome re-sequencing of homozygous 
mutant  harness  racing  horses  which  compete  in  pace  and  trot  respectively. 
Furthermore,  collecting  phenotypic  information  about  the  pattern  of 
locomotion in gaited horse breeds segregating for the DMRT3 mutation can 
give us the opportunity to investigate the effect of the mutation in each specific 
breed. It is likely that the homozygous and heterozygous horses will differ 
phenotypically, as they do in the Icelandic Horse breed. It is worth noting that 
in many horse breeds pace is not a valued gait and riders train their ambling 
horses  to  avoid  this  lateral  and  sometimes  quite  uncomfortable  gait.  In 
Icelandic horses, pace is only ridden over short distances at a very high speed. 
 
Obviously,  the  identification  of  this  major  Gait  locus  in  horses  will  have 
practical implications. The large effects seen in racing performance make the 
mutation particularly valuable for diagnostic testing in these horses. Whilst this 
may  lead  to  faster  genetic  gains,  saving  money  and  time  for  owners  and 
trainers, it is of equal importance to a horse welfare perspective, since only 
horses with the right pre-conditions may be set in training. CA and CC horses 
likely need more training and many never reach the level required for entering 
a race, which might have led to a decision to slaughter the animal in the past. 
However, CA and CC Standardbred horses are likely to become better riding 
horses compared to AA (because of a superior ability to canter), which might   47 
increase their value for this market instead. There is also an increased risk of 
injury  in  CA  and  CC  horses  when  used  for  harness  racing  as  they  have 
difficulties in synchronizing trot at high speed. DNA testing may thus aid in 
matching the right horse to the right purpose, which is positive for both trainers 
and  horses.  Genetic  testing  can  also  be  applied  to  Icelandic  horses.  This 
application would trace if the wild type allele from a four-gaited sire and/or 
dam has been transmitted to offspring. The identification of this major locus 
can also aid in the creation of new gaited horse breeds. For example, there is a 
group within the Morgan breed called “gaited Morgans” and genetic testing of 
these horses might aid in the creation of a distinct breed. The opportunities that 
are emerging are fascinating and it will be interesting to see how testing will be 
used and how this shapes the future development of different breeds. 
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Conclusions 
The studies presented in this thesis have assisted in the functional annotation of 
the mammalian genome and also have practical implications for horse welfare. 
Reconnecting to the aims of this thesis, the specific conclusions are: 
 
 
I  Mutant  PMEL  causes  Multiple  Congenital  Ocular  Anomalies  syndrome. 
The disease is undoubtedly inherited as an incompletely dominant trait. We 
were unable to detect anomalies in 6% of carriers, potentially because of 
incomplete penetrance. 
 
II  Variants  in  the  MHC-II  region  influence  susceptibility  to  Insect  Bite 
Hypersensitivity. The same marker risk allele was present in two distinct 
populations,  OR  4.19  (p=  2.34x10
-5)  and  1.48  (p=  0.043)  for  Icelandic 
horses and Exmoor ponies respectively. In addition, homozygousity across 
the MHC-II region confers a higher risk of developing disease, OR= 2.67 
(p= 0.0013). 
 
III  We have identified the first Gait locus in horses. A nonsense mutation in 
the transcription factor DMRT3 is permissive for alternative gaits across 
multiple  breeds.  The  lateral  gait  pace  show  recessive  inheritance  with 
incomplete penetrance in Icelandic horses. The DMRT3 mutation also has a 
favorable effect on racing performance. Further analysis in mice shows that 
gene  disruption  changes  spinal  cord  signaling,  neuron  development  and 
ultimately locomotion. 
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